Navigation Links
NOAA bans commercial harvesting of krill
Date:7/13/2009

The National Oceanic and Atmospheric Administration (NOAA) today published a final rule in the Federal Register prohibiting the harvesting of krill in the Exclusive Economic Zone (EEZ) off the coasts of California, Oregon, and Washington. The rule goes into effect on August 12, 2009. Krill are a small shrimp-like crustacean and a key source of nutrition in the marine food web.

"Krill are the foundation for a healthy marine ecosystem," said Mark Helvey, NOAA's Fisheries Service Southwest Assistant Regional Administrator for Sustainable Fisheries. "Protecting this vital food resource will help protect and maintain marine resources and put federal regulations in line with West-Coast states."

While the States of California, Oregon and Washington currently have regulations prohibiting the harvesting of krill within three miles of their coastlines, there was no similar federal restriction within the three to 200-mile confines of the EEZ.

The krill prohibition was adopted as Amendment 12 to the Coastal Pelagic Species Fishery Management Plan (FMP), which was developed by the Pacific Fishery Management Council (PFMC) under the Magnuson-Stevens Fishery Conservation and Management Act. The krill harvest prohibition was originally proposed to the PFMC and NOAA Fisheries Service by NOAA's Office of National Marine Sanctuaries. Today's rule implements Amendment 12 to the FMP and is intended to preserve key nutritional relationships in the California Current ecosystem, which includes five National Marine Sanctuaries.

"This is a great success for protecting the entire California Current ecosystem", said William Douros, West Coast Regional Director for NOAA's Office of National Marine Sanctuaries. "This decision reflects strong teamwork within NOAA and a commitment to addressing the issues raised by the Pacific Fishery Management Council and Sanctuary Advisory Councils."

Amendment 12 adds all species of krill under a new ca
'/>"/>

Contact: Jim Milbury
Jim.Milbury@noaa.gov
562-980-4006
NOAA Headquarters
Source:Eurekalert

Page: 1 2

Related biology news :

1. CSIRO deal to commercialize artificial gut
2. Demonstration Features Commercial Technology for Combating Terrorism
3. Demonstration Features Commercial Technology for Combating Terrorism
4. Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration
5. Commercial ships spew half as much particulate pollution as worlds cars
6. Commercial yeasts upgraded with an enzyme for biofuel production
7. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
8. Commercial aquatic plants offer cost-effective method for treating wastewater
9. MSU technology that converts plant fibers to biofuel commercialized
10. OHSU commercial collaborations have surged
11. Commercialization aim of grant supporting technology that destroys cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013) The AGA Research Foundation announced a new ... between the gut microbiota, one of today,s most exciting ... , The AGA Research Awards Panel selected Andrew T. ... Hospital and Harvard Medical School, Boston, as the 2013 ... will receive $25,000 of funding, commencing in July 2013, ...
(Date:5/17/2013)... May 17, 2013, Shenzhen, China---- Why Tibetan antelope ... Qinghai-Tibetan Plateau? In a collaborative research published in ... BGI, and other institutes provide evidence that some ... adaption to harsh highland environments. The data in ... specific genetic mechanisms and the biology of other ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... found a group of mutations involved in T-cell acute ... in clinical use to treat other diseases, can eliminate ... next week in Nature Genetics and may ... The study was led by researcher Joo T. ...
... that predisposes people to acute myeloid leukemia and myelodysplasia ... the GATA2 gene. Among its several regulatory roles, ... transition of primitive blood-forming cells into white blood cells. ... families who, over generations, have had several relatives with ...
... & Dentistry at the University of Alberta have discovered that ... syndrome in some offspring that could lead to later health ... nuts and red wine, and has been shown to extend ... growing in the womb have an increased risk of developing ...
Cached Biology News:New mutations in leukemia: Researchers found mechanism that can help design future therapies 2New mutations in leukemia: Researchers found mechanism that can help design future therapies 3Gene defect that predisposes people to leukemia discovered 2Gene defect that predisposes people to leukemia discovered 3Powerful antioxidant resveratrol prevents metabolic syndrome in lab tests: U of A study 2
(Date:5/17/2013)... world-leading provider of scientific, technical and medical information products ... study in Reproductive BioMedicine Online ... an abnormal chromosomal composition can be identified by the ... classifying the risk of genetic abnormality without a biopsy. ... a retrospective study, using their predictive model to assess ...
(Date:5/17/2013)... RESEARCH TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... drought and insect pressures , Syngenta ... grand opening celebration today at the company’s RTP Innovation ... Crop Lab allows company researchers to simulate any agricultural ...
(Date:5/17/2013)... 2013  Cellular Biomedicine Group (OTCQB: CBMG) today ... the total projected enrollment required for its Phase ... efficacy of the medical technology haMPC (Human Adipose-derived ... To date the trial has had no Severe ... I open label clinical research trial for KOA, ...
(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce ... Switzerland -based Kenta Biotech to acquire ... (mAb) products, and technologies. This asset portfolio purchase ... of infections by common pathogens including drug resistant ... Pseudomonas aeruginosa , Acinetobacter baumannii and ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Jan. 12 Synvista Therapeutics, Inc. (NYSE Alternext ... its BENEFICIAL study, a Phase 2 double-blind, placebo-controlled, randomized trial ... measure the effect of alagebrium on exercise tolerance in patients ... completing enrollment of its BREAK ( B eginning a ...
... Ill. and SANTA ANA, Calif., Jan. 12 ,Abbott ( NYSE: ... EYE ) announced,today a definitive agreement for Abbott to acquire ... value of approximately $2.8 billion, inclusive,of estimated net debt at ... AMO,is a global leader in ophthalmic care, comprised of three ...
... Bavarian Nordic,owns several United States patents relating ... MVA-BN(R), which is the basis for its smallpox,vaccine, ... for delivering,recombinant vaccines. Bavarian Nordic has asserted three ... The claim in this case is that Oxford,BioMedica ...
Cached Biology Technology:Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7Bavarian Nordic's Case Against Oxford BioMedica 2
Direct ELISA Assay Diluent, 100 mL...
Direct ELISA Assay Diluent, 10 L...
HRP Monoclonal-Goat Diluent - 5X Concentrate, 25 mL...
... routine agarose gel electrophoresis into an automated, ... This bufferless, pre-cast system is ideal for ... digests, and more. Fully automated, robot-compatible, and ... 96 system makes your high-throughput screening assignments ...
Biology Products: